|
|
|
Volumn 312, Issue 7028, 1996, Pages 442-
|
|
Drug companies should report side effects in terms of frequency [6]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG;
FLUOXETINE;
ADVERSE DRUG REACTION;
COST BENEFIT ANALYSIS;
DRUG INDUSTRY;
DRUG SAFETY;
LETTER;
PHYSICIAN;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
DRUG INDUSTRY;
FAMILY PRACTICE;
HUMANS;
INTERPROFESSIONAL RELATIONS;
|
|
EID: 0030020548
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (7)
|
|
References (0)
|
